Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma

出版年份 2018 全文链接

标题

作者

关键词

出版物

Volume 37, Issue 2, Pages 125-134

出版商

American Society of Clinical Oncology (ASCO)

发表日期

2018-11-20

DOI

10.1200/jco.18.00545

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.